LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

Clinical trial NCT04402957 · COMPLETED

Trial details

NCT number: NCT04402957
Sponsor: Arch Biopartners Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID Severe Acute Respiratory Syndrome Sars-CoV2 Acute Kidney Injury Acute Respiratory Distress Syndrome

Start date: 2020-10-14
Primary completion: 2021-05-27
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.